Associated Papers
Novel CYP2C9 promoter variants and assessment of their impact on gene expression.
Kramer MA et al.
Molecular Pharmacology, 2008
Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population.
Lee SC et al.
Clinical Pharmacology and Therapeutics, 2006
Functional characterization of novel allelic variants of CYP2C9 recently discovered in southeast Asians.
DeLozier TC et al.
The Journal of Pharmacology and Experimental Therapeutics, 2005
Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose.
Zhao F et al.
Clinical Pharmacology and Therapeutics, 2004
Pharmacogenetics of acenocoumarol pharmacodynamics.
Morin S et al.
Clinical Pharmacology and Therapeutics, 2004
Clinical relevance of genetic polymorphisms in the human CYP2C9 gene.
Schwarz UI
European Journal of Clinical Investigation, 2003
Genetic polymorphisms and functional characterization of the 5'-flanking region of the human CYP2C9 gene: in vitro and in vivo studies.
Shintani M et al.
Clinical Pharmacology and Therapeutics, 2001
Select a paper to view details